Grenke (GLJ) Given a €96.00 Price Target by HSBC Analysts

Share on StockTwits

Grenke (ETR:GLJ) has been assigned a €96.00 ($111.63) target price by equities researchers at HSBC in a report issued on Thursday. The firm presently has a “buy” rating on the stock. HSBC’s price target suggests a potential upside of 30.43% from the stock’s previous close.

GLJ has been the topic of a number of other reports. Berenberg Bank set a €81.00 ($94.19) price objective on shares of Grenke and gave the stock a “neutral” rating in a report on Tuesday. Warburg Research set a €105.00 ($122.09) price objective on shares of Grenke and gave the stock a “buy” rating in a report on Tuesday, October 30th. Commerzbank set a €90.00 ($104.65) price objective on shares of Grenke and gave the stock a “neutral” rating in a report on Friday, October 26th. Finally, Deutsche Bank set a €107.00 ($124.42) price objective on shares of Grenke and gave the stock a “buy” rating in a report on Tuesday, November 6th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of €93.17 ($108.33).

GLJ opened at €73.60 ($85.58) on Thursday.

Grenke Company Profile

Grenke AG engages in the leasing, banking, and factoring businesses in Germany and internationally. The company is involved in the leasing activities, such as financing to commercial lessees, rental, insurance, service, and maintenance offerings, as well as disposal of used equipment; and small-ticket leasing of IT products, such as PCs, notebooks, servers, monitors, peripheral devices, software, and telecommunication and copier equipment, as well as other IT products.

Featured Story: What is a front-end load?

Analyst Recommendations for Grenke (ETR:GLJ)

Receive News & Ratings for Grenke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grenke and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Brokerages Anticipate Repligen Co.  Will Post Quarterly Sales of $50.33 Million
Zacks: Brokerages Anticipate Repligen Co. Will Post Quarterly Sales of $50.33 Million
Stealth 24-Hour Volume Tops $138.00
Stealth 24-Hour Volume Tops $138.00
Molecular Future  1-Day Volume Tops $421,889.00
Molecular Future 1-Day Volume Tops $421,889.00
Deutsche Lufthansa AG  Receives Consensus Recommendation of “Hold” from Brokerages
Deutsche Lufthansa AG Receives Consensus Recommendation of “Hold” from Brokerages
Heat Biologics  Trading Down 4.3%
Heat Biologics Trading Down 4.3%
Tyme Technologies  Sees Unusually-High Trading Volume
Tyme Technologies Sees Unusually-High Trading Volume


Leave a Reply

© 2006-2019 Ticker Report